2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Sunday, October 7, 2018

1:45pm-3:15pm: Parkinson’s Disease Psychosis Associated Comorbidities, and Mortality in the Medicare Population

D. Weintraub, A. Willis, P. Torres, A. Shim, J. Norton, K. Liu, G. Demos (Philadelphia, PA, USA)

Epidemiology · Hall 3FG

1:45pm-3:15pm: Parkinson’s disease-related non-motor features as risk factors for post-operative delirium in spinal surgery

SY. Kang, KH. Kim, DA. Shim, SW. Choi, MJ. Son, YH. Sohn, PH. Lee (Hwaseong, Republic of Korea)

Other · Hall 3FG

1:45pm-3:15pm: Parkinson’s disease, peripheral neuropathy, impaired gait, and the role of physiotherapy

M. Alvarez (San Antonio, TX, USA)

Other · Hall 3FG

1:45pm-3:15pm: Parkinsonism with rare sequence variants in VPS35 and FBXO7 genes associated with Lewy body pathology

K. Mensikova, L. Tuckova, R. Vodicka, K. Kolarikova, T. Bartonikova, J. Ehrmann, R. Vrtel, P. Kanovsky (Olomouc, Czech Republic)

Other · Hall 3FG

1:45pm-3:15pm: Paroxysmal kinesigenic dyskinesia successfully treated with lamotrigine –description of 2 cases

E. Papuć, K. Rejdak (Lublin, Poland)

Dystonia · Hall 3FG

1:45pm-3:15pm: Paroxysmal multifocal dystonia with hemiplegic migraine possibly related to novel CACNA1A mutation

A. Hannoun, K. Smith (Worcester, MA, USA)

Dystonia · Hall 3FG

1:45pm-3:15pm: Pathophysiologic insights into ataxia and spasticity through structural imaging of a spinocerebellar ataxia type 7 (SCA7) cohort

J. Parker, S. Merchant, S. Horovitz, M. Hallett (Bethesda, MD, USA)

Ataxia · Hall 3FG

1:45pm-3:15pm: Patient Perceptions of Dopaminergic Therapy Withdrawal in Parkinson’s disease

N. Kukreti, P. Trujillo-Diaz, N. Van Wouwe, D. Claassen (Nashville, TN, USA)

Phenomenology and Clinical Assessment Of Movement Disorders · Hall 3FG

1:45pm-3:15pm: Patient Perspective in Multiple System Atrophy

A. Mahajan, Z. Mari (Detroit, MI, USA)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG

1:45pm-3:15pm: PBT434 prevents the accumulation of glial cell inclusions and insoluble alpha-synuclein in a mouse model of Multiple System Atrophy

D. Finkelstein, P. Adlard, N. Stefanova, D. Stamler (Parkville, Vic, Australia)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG